Von Hippel-Lindau (VHL) Program at Northwestern Memorial Hospital
Northwestern Memorial Hospital is recognized by the VHL Alliance as a Clinical Care Center (CCC). Our multidisciplinary VHL team is committed to providing holistic, coordinated care for patients with VHL and for their families. To learn more or to make an appointment, email vhl@nm.org or call 312.926.0409, TTY 711.
About VHL Disease
VHL disease is a hereditary condition characterized by tumors that can occur in one or more areas of the body. These tumors can be benign (noncancerous) or malignant (cancerous). However, even benign VHL-associated tumors can cause medical problems.
Not every individual with VHL has the same presentation, and it can be difficult to predict how someone may be affected. Tumors may include:
- Central nervous system (cerebellar, brainstem and spinal) hemangioblastomas
- Retinal hemangioblastomas
- Endolymphatic sac tumors
- Epididymal cysts
- Pancreatic neuroendocrine tumors and cysts
- Pheochromocytomas and paragangliomas
- Renal cell carcinoma
Expert Diagnosis, Screening and Treatment
Patients with VHL, as well as people with known family history of VHL, can benefit from care provided by a team that has recognized experience with this complex condition. Early detection, active surveillance and appropriate treatment can greatly reduce the most serious consequences of VHL.
The VHL Program at Northwestern Memorial Hospital includes a multidisciplinary team of experienced specialists who work together to keep patients healthy by detecting tumors early. If a tumor is detected, expert treatment is available through the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. In addition, genetic counselors with in-depth knowledge of VHL are available to provide advice and support.